Grassley Unsatisfied With FDA Commissioner-Nominee Von Eschenbach
This article was originally published in The Gray Sheet
Executive Summary
Sen. Chuck Grassley (R-Iowa) signaled Nov. 30 he is not ready to back down from strong reservations about confirming FDA Acting Commissioner Andrew von Eschenbach to the permanent post after receiving the nominee's 1responses to 15 questions
You may also be interested in...
Von Eschenbach Clears Senate Handily After Months Of Debate
Andrew von Eschenbach can officially take the helm of FDA, following confirmation by the Senate Dec. 7
Von Eschenbach Clears Senate Handily After Months Of Debate
Andrew von Eschenbach can officially take the helm of FDA, following confirmation by the Senate Dec. 7
Advisory Panel Conflict Waivers To Stay; FDA Will Provide Clarity On Process
FDA's plan for improving its advisory committee member selection process focuses on increasing the transparency and consistency of the existing process rather than a more extensive overhaul